Loading insider details...
Beta
Latest Form 4 (Sep 8, 2026): In-the-Money Exercise of 4,587 AQST shares, $4.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Aquestive Therapeutics, Inc. (AQST) | In-the-Money Exercise | 4,587 | $4.4K |
| May 7, 2026 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 72,734 | $304.0K |
| Apr 13, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 60,000 | n/a |
| Mar 11, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 80,000 | n/a |
| Oct 17, 2025 | Aquestive Therapeutics, Inc. (AQST) | Exercise/Conversion | 25,000 | $77.6K |
| Sep 8, 2025 | Aquestive Therapeutics, Inc. (AQST) | Exercise/Conversion | 25,000 | $78.8K |
| Mar 11, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 80,000 | n/a |
| Nov 27, 2024 | Aquestive Therapeutics, Inc. (AQST) | Sale | 44 | $214.06 |
| Mar 12, 2024 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 8,300 | $40.5K |
| Mar 11, 2024 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 1,365 | n/a |